Labshake search

1 - 11 of 11 citations for 7 Benzothiazolemethanol 2 amino 6 methoxymethyl 9CI since 2019

• Network and systems based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapy

  Xin Lai, et al., bioRxiv - Systems Biology 2020

  Quote: ... 1 000 U/mL IL-6 (CellGenix), 10 ng/mL TNF (Beromun ...
• WNT6-ACC2-induced accumulation of triacylglycerol rich lipid droplets is exploited by M. tuberculosis

  Julius Brandenburg, et al., bioRxiv - Immunology 2020

  Quote: ... isolated cells were incubated for 7 days in Teflon bags (VueLife 72C; Cellgenix, Freiburg, Germany) in VLE RPMI 1640 (Biochrome ...
• Directed Evolution of Adenine Base Editors with Increased Activity and Therapeutic Application

  Nicole M. Gaudelli, et al., bioRxiv - Genomics 2020

  Quote: ... and 250IU/mL of recombinant human interleukin-2 (rhIL-2, CellGenix GmbH). Cells were activated with soluble human anti-CD3 (clone OKT3 ...
• Adaptation to ex vivo culture drives human haematopoietic stem cell loss of repopulation capacity in a cell cycle independent manner

  Carys S. Johnson, et al., bioRxiv - Cell Biology 2023

  Quote: ... 2) GT culture conditions: GMP SCGM (CellGenix) supplemented with L-Glutamine (1% ...
• PD-L1 blockade restores CAR T cell activity through IFNγ-regulation of CD163+ macrophages

  Yukiko Yamaguchi, et al., bioRxiv - Immunology 2022

  Quote: ... containing 100 U/mL recombinant human IL-2 (rhIL-2, Novartis Oncology) and 0.5 ng/mL recombinant human IL-15 (rhIL-15, CellGenix). For CAR lentiviral transduction ...
• Single-cell functional genomics of natural killer cell evasion in blood cancers

  Olli Dufva, et al., bioRxiv - Immunology 2022

  Quote: ... CD3-negative PBMCs were then seeded in 6-well plates at a density of 1×106 cells/ml in GMP SCGM media (CellGenix) with 10% heat-inactivated FBS ...
• BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved antitumor activity

  Taylor L. Hickman, et al., bioRxiv - Cancer Biology 2022

  Quote: ... and IL-2 (100 U/ml) (Cellgenix Cat# 1020-050) for 2 days ...
• B cell directed CAR-T cell therapy results in activation of CD8+ cytotoxic CAR-negative bystander T cells in both non-human primates and patients

  James Kaminski, et al., bioRxiv - Immunology 2023

  Quote: ... and recombinant human IL-2 (rhIL2,50 U/mL; R&D Systems/CellGenix)) with or without 1% penicillin/streptomycin/l-glutamine (Invitrogen) ...
• Invariant chain with an AP3 interacting sorting signal is sorted to late endosomal compartments and may improve MHC class I loading and presentation

  Ana Kucera, et al., bioRxiv - Immunology 2020

  Quote: ... monocytes obtained from leukapheresis product (REC Project no: 2013/624-15) were cultured for 2 days in CellGro DC medium (CellGenix, Freiburg, Germany) supplemented with GM-CSF and Interleukin-4 (IL-4 ...
• Inhibition of the αv integrin-TGF-β axis improves natural killer cell function against glioblastoma stem cells

  Hila Shaim, et al., bioRxiv - Immunology 2020

  Quote: ... NK ratio and recombinant human IL-2 (Proleukin, 200 U/ml; Chiron, Emeryville, CA, USA) in complete CellGenix GMP SCGM Stem Cell Growth Medium (CellGenix GmbH, Freiburg, Germany) on day 0 ...
• CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor

  May Daher, et al., bioRxiv - Immunology 2020

  Quote: ... at 2:1 feeder cell:NK ratio and recombinant human IL-2 (Proleukin, 200 Chiron, Emeryville, CA, USA) in complete stem cell growth medium (SCGM, CellGenix GmbH, Freiburg, Germany) on day 0 ...